PHARMANUTRA S.P.A. OBTAINS PATENT FOR A NEW COMPOSITION USED FOR TREATING CARDIOVASCULAR DISEASES

Related News

• Two news patents approved in India and US...

  The Group obtains approval of the Cetilar® patent in the USA and new prospects unfold for SiderAL®...

• PharmaNutra will sponsor five new ECM eve...

  All the appointments organised by AIC Group with the support of PharmaNutra will take place in Italy...

Related Products

• Gestalys DHA

  Gestalys DHA is a nutritional supplement specifically formulated according to LARN (Recommended Nutrition...

• SiderAL Folic 30

  Sideral Folic 30: the only real mouth-dispersible Sucrosomial^® Iron. Sideral Folic 30...